U.S. Blood Testing Market (2025 - 2033) Size, Share & Trends Analysis Report By Test Type (Glucose, A1C, Direct LDL, Lipid Pane, Prostate-specific Antigen, COVID-19, BUN, Vitamin D, Thyroid-stimulating Hormone, Serum Nicotine/Cotinine, High sensitivity CRP), And Segment Forecasts
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type outlook
2.3. Competitive Insights
Chapter 3. U.S. Blood Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Blood Testing Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. U.S. Blood Testing Market: Test Type Estimates & Trend Analysis
4.1. Test Type Segment Dashboard
4.2. U.S. Blood Testing Market: Test Type Movement Analysis
4.3. U.S. Blood Testing Market Size & Trend Analysis, by Test Type, 2021 to 2033 (USD Billion)
4.4. Glucose Testing
4.4.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.5. A1C Testing
4.5.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.6. Direct LDL testing
4.6.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.7. Lipid Panel Testing
4.7.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.8. Prostate-Specific Antigen Testing
4.8.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.9. Covid-19 Testing
4.9.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.10. BUN Testing
4.10.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.11. Vitamin D Testing
4.11.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.12. Thyroid-Stimulating Hormone Testing
4.12.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.13. Serum Nicotine/Cotinine Testing
4.13.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.14. High Sensitivity CRP Testing
4.14.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.15. Testosterone Testing
4.15.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.16. ALT Testing
4.16.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.17. Cortisol Testing
4.17.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.18. Creatinine Testing
4.18.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.19. AST Testing
4.19.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
4.20. Other Blood Tests
4.20.1. Market estimates and forecasts 2021 to 2033 (USD Billion)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. Key company heat map analysis, 2024
5.4. Company Profiles
5.4.1. Abbott
5.4.1.1. Company overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. F. Hoffmann-La Roche Ltd
5.4.2.1. Company overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Bio-Rad Laboratories, Inc.
5.4.3.1. Company overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. BIOMÉRIEUX
5.4.4.1. Company overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Biomerica
5.4.5.1. Company overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
5.4.6. BD
5.4.6.1. Company overview
5.4.6.2. Financial performance
5.4.6.3. Product benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Quest Diagnostics Incorporated
5.4.7.1. Company overview
5.4.7.2. Financial performance
5.4.7.3. Product benchmarking
5.4.7.4. Strategic initiatives
5.4.8. Siemens Healthineers AG
5.4.8.1. Company overview
5.4.8.2. Financial performance
5.4.8.3. Product benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Danaher Corporation
5.4.9.1. Company overview
5.4.9.2. Financial performance
5.4.9.3. Product benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Trinity Biotech Plc
5.4.10.1. Company overview
5.4.10.2. Financial performance
5.4.10.3. Product benchmarking
5.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. blood testing market estimates and forecasts, 2021 - 2033 (USD Billion)
Table 3 U.S. blood testing market, by test type, 2021 - 2033 (USD Billion)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. blood testing market: market outlook
Fig. 10 Blood testing competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. blood testing market driver impact
Fig. 16 U.S. blood testing market restraint impact
Fig. 17 U.S. blood testing market strategic initiatives analysis
Fig. 18 U.S. blood testing market: Test type movement analysis
Fig. 19 U.S. blood testing market: Test type outlook and key takeaways
Fig. 20 Glucose testing market estimates and forecast, 2021 - 2033
Fig. 21 A1C testing market estimates and forecast, 2021 - 2033
Fig. 22 Direct LDL testing market estimates and forecast, 2021 - 2033
Fig. 23 Lipid panel testing market estimates and forecast, 2021 - 2033
Fig. 24 Prostate-specific antigen testing market estimates and forecast, 2021 - 2033
Fig. 25 COVID-19 testing market estimates and forecast, 2021 - 2033
Fig. 26 BUN testing market estimates and forecast, 2021 - 2033
Fig. 27 Vitamin D testing market estimates and forecast, 2021 - 2033
Fig. 28 Thyroid-stimulating hormone (TSH) market estimates and forecast, 2021 - 2033
Fig. 29 Serum nicotine/cotinine market estimates and forecast, 2021 - 2033
Fig. 30 High sensitivity CRP testing market estimates and forecast, 2021 - 2033
Fig. 31 Testosterone testing market estimates and forecast, 2021 - 2033
Fig. 32 ALT testing market estimates and forecast, 2021 - 2033
Fig. 33 Cortisol testing market estimates and forecast, 2021 - 2033
Fig. 34 Creatinine testing market estimates and forecast, 2021 - 2033
Fig. 35 AST testing market estimates and forecast, 2021 - 2033
Fig. 36 Other blood tests market estimates and forecast, 2021 - 2033
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
